By:DengYue International Business Division In recent years, the global rare disease landscape has shifted from symptomatic management to mechanism-based intervention. Across lysosomal storage disorders, immune-mediated hematologic diseases, and amyloidosis, enzyme replacement ...Learn More

By:DengYue International Business Division As a Hong Kong–based pharmaceutical export enterprise with long-standing expertise in international drug quality systems and global supply chain management, DengYueMed continuously monitors clinical progress and industry developments in ...Learn More

IgG4-related disease (IgG4-RD) is a systemic immune-mediated disorder characterized by chronic inflammation and progressive fibrosis. Since the disease was systematically defined, its clinical spectrum has expanded continuously. It is now known to affect multiple organs, including ...Learn More

2026.02.11 Written by DengyueMedIn the global rare disease landscape, the treatment of Spinal Muscular Atrophy (SMA) has achieved milestone progress in recent years. With the successive approvals of gene-targeted therapies and splicing-modifying drugs, SMA is gradually ...Learn More

In the long process of sorting out data on immune-related diseases and medications, Deng Yue found that myasthenia gravis is a disease that is often mentioned but easily misunderstood.Many people are frightened by the word "severe" when they hear the name for the first time, but ...Learn More